Skip to main content
Elsevier

Gold Nanoparticle Therapeutics in Alzheimer's Disease

Revolutionizing Diagnosis and Treatment

  • 1st Edition - March 20, 2027
  • Latest edition
  • Editors: Arun Kumar Singh, Mahesh Narayan, Ashutosh Pareek
  • Language: English

Gold Nanoparticle Therapeutics in Alzheimer's Disease: Revolutionizing Diagnosis and Treatment is an essential resource that delves into the groundbreaking use of nanote… Read more

Description

Gold Nanoparticle Therapeutics in Alzheimer's Disease: Revolutionizing Diagnosis and Treatment is an essential resource that delves into the groundbreaking use of nanotechnology in the fight against one of the most challenging neurodegenerative disorders. This volume offers an in-depth exploration on how gold nanoparticles can be used to enhance the diagnosis, treatment, and overall understanding of Alzheimer's disease. By examining the molecular mechanisms that enable nanoparticles to cross the blood-brain barrier, the book highlights their role in inhibiting amyloid fibrils and their potential as precise diagnostic tools.

Covering a wide range of topics, this comprehensive guide serves as an invaluable reference for researchers, clinicians, and industry professionals at the forefront of Alzheimer's research and nanomedicine.

Key features

  • Provides practical examples and case studies, illustrating how these mechanisms can be utilized in real-world scenarios
  • Describes the specific mechanisms through which nanocarrier-based delivery systems can enhance drug effectiveness
  • Includes an extensive review on how gold nanoparticles have been used in various therapeutic contexts

Readership

Researchers, clinicians, and graduate students in the fields of Alzheimer's research and nanotechnology

Table of contents

1. Introduction to Alzheimer’s Disease: Current Challenges and Opportunities

2. Fundamentals of Gold Nanoparticles: Properties, Synthesis, and Functionalization

3. Pathophysiological Mechanisms of Alzheimer’s Disease and Gold Nanoparticles Intervention

4. Diagnostic Applications of Gold Nanoparticles in Alzheimer’s Disease

5. Gold Nanoparticles for Drug Delivery in Alzheimer’s Disease

6. Glyco-Gold Nanoparticles: Advances in Targeted Therapy for Alzheimer’s Disease

7. Nucleic Acid-Based Therapies Delivered by Gold Nanoparticles

8. Immunotherapeutic Approaches Using Gold Nanoparticles in Alzheimer’s Disease

9. Regenerative Medicine: Gold Nanoparticles in Neural Tissue Repair

10. Clinical Translation of Gold Nanoparticle Therapies: Challenges and Opportunities

11. Ethical Considerations and Regulatory Aspects of Gold Nanoparticle Use

12. Future Perspectives and Emerging Trends in Gold Nanoparticle Research for Alzheimer’s Disease

Product details

  • Edition: 1
  • Latest edition
  • Published: March 20, 2027
  • Language: English

About the editors

AS

Arun Kumar Singh

Arun Kumar Singh is Assistant Professor in the Department of Pharmacy at the University School of Pharmaceutical Sciences, Rayat Bahra University, Sahauran, India. His research interests include nano-formulation, cancer biology, and neuroscience, alongside digital and computational approaches such as machine learning, artificial intelligence, big data analytics, blockchain, and the Internet of Things. He has contributed academic books, book chapters, and review articles in pharmaceutical sciences and healthcare technology, with a focus on interdisciplinary approaches that integrate pharmaceutical research with emerging digital technologies.

Affiliations and expertise
Assistant Professor, University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, Tehsil Kharar, Distt. Mohali, Punjab, India

MN

Mahesh Narayan

Dr. Mahesh Narayan is a Professor in the Department of Chemistry and Biochemistry at the University of Texas at El Paso (USA). He earned a B.Sc. in Physics from Bombay University (1991) and a Ph.D. in Biophysics from The Ohio State University (1997). He completed postdoctoral studies at Cornell University (1997–2000) and later served as a Senior Research Associate there (2002–2005). Dr. Narayan has authored and co-authored articles and book chapters in free radical biology, protein structure-function relationships, oxidative folding, protein misfolding, halogen bonding, in silico drug design, the agricultural impact of nanomaterials, and chemical education. His work has been recognized by invitations to speak at over 15 international forums and by coverage in various media outlets. His research focuses on intracellular mechanisms in neurodegenerative disorders, particularly the effects of xenobiotics on amyloid proteins.
Affiliations and expertise
Full Professor, University of Texas at El Paso, USA

AP

Ashutosh Pareek

Ashutosh Pareek is Professor at Banasthali Vidyapith, India, with expertise in neuropharmacology and advanced drug delivery systems. His research focuses on therapeutic strategies for neurodegenerative disorders, cancer, autoimmune diseases, and related health conditions, with particular interest in the development of innovative drug delivery approaches for bioactive and immunomodulatory compounds. Dr. Pareek leads research initiatives in these areas and collaborates with national and international funding agencies on projects that advance pharmaceutical science and translational research. He has contributed extensively to the scientific literature through scholarly publications, books, patents, and research mentorship. In addition, he serves on editorial and peer-review activities for international journals in pharmacology and oncology, supporting the dissemination and evaluation of research across the biomedical sciences.

Affiliations and expertise
Professor, Department of Pharmacy, Banasthali Vidyapith, Banasthali, Tonk, Rajasthan, India